ImmunoPrecise Antibodies Ltd (IPA)
0.4001
-0.02
(-4.76%)
USD |
NASDAQ |
Dec 20, 16:00
0.4014
0.00 (0.00%)
After-Hours: 20:00
ImmunoPrecise Antibodies Profit Margin (Quarterly): -41.68% for Oct. 31, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 21.17% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -2.60K% |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -68.99% |
| Return on Assets | -41.65% |
| Return on Invested Capital | -67.12% |
| Gross Profit Margin (Quarterly) | 56.11% |
| Operating Margin (Quarterly) | -46.02% |
| Return on Net Operating Assets | -41.71% |